GLOBAL LIFE SCIENCE VENTURES
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance, advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerla... nd, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
GLOBAL LIFE SCIENCE VENTURES
Industry:
Financial Services Life Science Venture Capital
Founded:
1996-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Apache Euro 1and1 Symantec.cloud Thomson Reuters Corporate Solutions
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-01-23 | Binx Health | Global Life Science Ventures investment in Series D - Binx Health | 35 M USD |
| 2015-01-29 | Binx Health | Global Life Science Ventures investment in Series C - Binx Health | 20 M USD |
| 2012-06-21 | Santaris Pharma | Global Life Science Ventures investment in Venture Round - Santaris Pharma | 12 M USD |
| 2010-07-16 | Action Pharma | Global Life Science Ventures investment in Series C - Action Pharma | 6.3 M USD |
| 2009-12-29 | Coapt Systems | Global Life Science Ventures investment in Debt Financing - Coapt Systems | 3.72 M USD |
| 2009-09-23 | Agendia | Global Life Science Ventures investment in Series E - Agendia | 23 M USD |
| 2007-12-30 | Santaris Pharma | Global Life Science Ventures investment in Series C - Santaris Pharma | 20.4 M EUR |
| 2007-08-28 | Agendia | Global Life Science Ventures investment in Series D - Agendia | 34 M USD |
| 2007-03-29 | Coapt Systems | Global Life Science Ventures investment in Series E - Coapt Systems | 22.6 M USD |
| 2007-03-29 | Nitec Pharma AG | Global Life Science Ventures investment in Series B - Nitec Pharma AG | 26 M USD |
More informations about "Global Life Science Ventures"
GLSV - Global Life Science Ventures
Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, …See details»
Global Life Science Ventures — Investing in the life sciences
Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, …See details»
Global Life Science Ventures - Crunchbase
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, …See details»
Global Life Science Ventures — Investing in the life sciences
Oxford Bioscience Partners is a life science venture capital firm that provides equity financing and management assistance to start-up and early-stage, entrepreneurial-driven companies in the …See details»
Global Life Science Ventures - Investments, Portfolio & Company …
Global Life Science Ventures is a swiss investment fund focusing exclusively on the life sciences sector. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ...See details»
Global Life Science Ventures - Funding, Financials ... - Crunchbase
Global Life Science Ventures . Connect to CRM . Save . Summary. Financials. Investments. People. Technology. Signals & News. Similar Companies. Highlights. Funds 2. Funding. …See details»
Life Sciences Funding in View | US | Cushman
Jan 29, 2024 Global life sciences venture capital funding has reverted to its pre-pandemic long-term trend. Peak pandemic funding and initial public offering activity in 2020 and 2021 resulted in the creation of many new life sciences …See details»
GLSV - Team and biographies - Global Life Science Ventures
Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, …See details»
Life Science Ventures – Life Science Ventures
Life Science Ventures, Inc., (LSV) is a management company headquartered in Indianapolis. We are focused on building innovative business models and strategic partnerships that drive profitable growth and performance …See details»
Taking life sciences to the next level – Ontario’s strategy
Learn how Ontario is aiming to establish ourselves as a global biomanufacturing and life sciences hub. Download PDF ... recording more than half of all venture capital investments in Canada with $8.4 billion including $846.8 million in life …See details»
Top 80 Life Sciences Venture Capital Firms in 2024
Jan 22, 2024 Lightstone Ventures is a life science early-stage venture capital firm. Details of the VC firm: Country: USA, Ireland, Singapore ... OneVentures is a renowned VC organization in Australia, investing in cutting-edge technology …See details»
2024 Global Life Sciences Sector Outlook - Deloitte
May 31, 2024 In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, changes in US …See details»
Global Life Science Ventures - Contacts, Employees, Board …
Global Life Science Ventures has 4 current employee profiles, including Chief Executive Officer Brad Van Pelt. Contacts. Edit Contacts Section. We're working on getting contact data for …See details»
GLSV - Contact - Global Life Science Ventures
Global Life Science Ventures (GLSV) was a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, …See details»
Canadian life sciences: VC investment report Q1 2022
May 17, 2022 As well, interest by U.S. and other foreign funds in Canadian life science companies continues to increase as the industry matures. Venture capital interest in larger …See details»
2024 Healthcare and Life Sciences Predictions - Bessemer Venture …
Jan 8, 2024 In 2024, we’ll learn more about the regulatory guardrails for healthcare and biomedical AI––such as the notion of nationwide healthcare AI assurance labs ––and we’ll …See details»
2024 Global Life Sciences Sector Outlook - Deloitte
May 31, 2024 With the global pandemic firmly in the rearview mirror, life sciences companies are looking at key macro- and micro-economic drivers to guide their future growth. While the list of …See details»
10 years’ investing in the life sciences - Global Life Science Ventures
By the Global Life Science Ventures team E urope’s biotech sector has come a long way since our start in 1996. More than $28 billion has been invested in the Euro-pean industry since, while …See details»
Vancouver readies for its position as a global ... - The Globe and Mail
Mar 9, 2024 Vancouver is already Canada’s fastest-growing biotech centre, with 8,000 jobs added over the past 10 years, up to nearly 20,000, while the number of businesses in B.C. …See details»
Global Life Science Ventures — Investing in the life sciences
Global Life Science Ventures (GLSV) is a leading, independent venture capital fund focusing exclusively on the life sciences. GLSV is dedicated to supporting early-stage groups, …See details»